Latest Women’s Business News and Insights
Renasant Bio CEO Emily Conley, former 23andMe exec snags $54.5 million to target deadly kidney disease (click article below)
Renasant Bio CEO Emily Conley, former 23andMe exec snags $54.5 million to target deadly kidney disease (click article below)